BioScrip® is a leading provider in comprehensive, cost-effective pharmaceutical and home care solutions. Our goal is to partner with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers to provide access to infusible medications and management solutions that optimize outcomes for chronic and other complex healthcare conditions. At BioScrip, our patients receive personalized, safe, effective and convenient infusion therapies to help improve quality of life. Our team of professionals assist each patient in every step of their office or home infusion experience.
Denver, US
Size (employees)
2,039 (est)
BioScrip is headquartered in Denver, US
Report incorrect company information

Key People/Management at BioScrip

Richard M. Smith

Richard M. Smith

President & CEO

BioScrip Office Locations

BioScrip has an office in Eden Prairie, Elmsford and Denver
Denver, US (HQ)
950 1600 Broadway
Eden Prairie, US
10050 Crosstown Circle
Elmsford, US
100 Clearbrook Road
Show all (3)
Report incorrect company information

BioScrip Financials and Metrics

BioScrip Financials

BioScrip's revenue was reported to be $935.59 m in FY, 2016 which is a 4.7% decrease from the previous period.

Revenue (FY, 2016)

935.6 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

265.6 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(41.5 m)

Market capitalization (5-Feb-2018)

373.5 m

Cash (3-Feb-2018)

33 m


819.1 m
BioScrip's current market capitalization is $373.5 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


842.2 m984.1 m982.2 m935.6 m

Revenue growth, %


Cost of goods sold

721.3 m670 m

Gross profit

260.9 m265.6 m
USDFY, 2015FY, 2016


15.6 m9.6 m


20 m36.2 m

Current Assets

187 m176.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


9.3 m1.5 m23.2 m1.2 m29.4 m8.1 m51.4 m2.8 m16 m40.5 m33 m


30.3 m34.8 m34.5 m33.8 m41.9 m42.4 m26.9 m29.1 m32.4 m33.4 m30.5 m28.8 m27.8 m

Current Assets

222.1 m251.3 m238.8 m215.6 m212.4 m185.4 m199.4 m158.8 m199 m159.4 m176 m190.5 m170.2 m


41.1 m40 m39.9 m40 m35.9 m34.9 m34.1 m30.5 m30.8 m33.7 m30.4 m30.1 m28.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(299.7 m)(41.5 m)

Depreciation and Amortization

22.7 m21.6 m


(5.8 m)10 m

Accounts Payable

(24.1 m)(20.5 m)
Show all financial metrics
Report incorrect company information